BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,345,514 | -64.4% | 592,091 | -57.1% | 0.06% | -62.0% |
| Q2 2023 | $62,854,348 | -60.6% | 1,379,595 | -64.9% | 0.16% | -65.4% |
| Q1 2023 | $159,490,640 | -8.9% | 3,932,215 | +14.5% | 0.46% | -17.1% |
| Q4 2022 | $175,062,683 | +552.6% | 3,434,622 | +589.7% | 0.55% | +504.4% |
| Q3 2022 | $26,824,000 | -68.5% | 498,023 | -62.4% | 0.09% | -67.6% |
| Q2 2022 | $85,165,000 | -22.6% | 1,325,933 | -6.6% | 0.28% | -13.5% |
| Q1 2022 | $110,074,000 | -48.5% | 1,419,583 | -42.9% | 0.32% | -28.7% |
| Q4 2021 | $213,537,000 | +6.8% | 2,487,614 | +0.1% | 0.46% | +2.0% |
| Q3 2021 | $199,945,000 | +20.3% | 2,485,951 | +20.4% | 0.45% | +18.6% |
| Q2 2021 | $166,155,000 | -23.4% | 2,064,041 | -19.8% | 0.38% | -33.3% |
| Q1 2021 | $217,043,000 | +16.7% | 2,573,430 | +11.0% | 0.56% | +5.8% |
| Q4 2020 | $186,000,000 | +144.8% | 2,318,049 | +145.3% | 0.53% | +97.8% |
| Q3 2020 | $75,994,000 | -34.6% | 944,964 | -30.0% | 0.27% | -53.1% |
| Q2 2020 | $116,283,000 | +171.1% | 1,350,557 | +155.7% | 0.58% | +65.0% |
| Q1 2020 | $42,891,000 | -45.2% | 528,276 | -43.5% | 0.35% | +48.5% |
| Q4 2019 | $78,232,000 | -31.5% | 935,575 | -28.3% | 0.24% | -38.8% |
| Q3 2019 | $114,163,000 | +72.6% | 1,305,158 | +61.6% | 0.38% | +73.8% |
| Q2 2019 | $66,135,000 | -13.1% | 807,495 | -13.7% | 0.22% | -10.5% |
| Q1 2019 | $76,070,000 | -7.4% | 935,550 | -12.2% | 0.25% | +10.3% |
| Q3 2018 | $82,119,000 | -4.8% | 1,065,242 | -8.9% | 0.22% | -13.2% |
| Q2 2018 | $86,298,000 | -12.0% | 1,168,707 | -22.5% | 0.26% | -20.9% |
| Q1 2018 | $98,047,000 | -30.2% | 1,507,492 | -30.6% | 0.33% | -28.7% |
| Q4 2017 | $140,407,000 | +1.8% | 2,172,145 | -1.1% | 0.46% | -6.5% |
| Q3 2017 | $137,885,000 | -5.6% | 2,197,366 | -9.0% | 0.49% | -7.6% |
| Q2 2017 | $146,134,000 | -20.7% | 2,413,844 | -32.1% | 0.53% | -14.7% |
| Q1 2017 | $184,257,000 | +15.2% | 3,552,969 | -1.5% | 0.62% | +1.1% |
| Q4 2016 | $159,900,000 | +1.3% | 3,606,220 | +8.7% | 0.61% | +7.0% |
| Q3 2016 | $157,869,000 | -10.2% | 3,316,582 | -14.7% | 0.57% | -24.1% |
| Q2 2016 | $175,865,000 | +126.3% | 3,889,121 | +105.6% | 0.76% | +104.6% |
| Q1 2016 | $77,706,000 | -7.9% | 1,891,580 | -14.5% | 0.37% | -8.9% |
| Q4 2015 | $84,364,000 | +80.7% | 2,211,373 | +55.6% | 0.40% | +68.8% |
| Q3 2015 | $46,688,000 | +44.9% | 1,421,246 | +208.4% | 0.24% | +60.0% |
| Q2 2015 | $32,224,000 | -58.8% | 460,807 | -59.6% | 0.15% | -61.0% |
| Q1 2015 | $78,197,000 | +734.6% | 1,141,563 | +774.5% | 0.38% | +816.7% |
| Q3 2014 | $9,369,000 | -90.7% | 130,539 | -90.6% | 0.04% | -90.7% |
| Q2 2014 | $100,745,000 | +306.0% | 1,393,428 | +290.6% | 0.45% | +231.4% |
| Q4 2013 | $24,811,000 | -69.0% | 356,733 | -70.7% | 0.14% | -73.1% |
| Q3 2013 | $80,087,000 | -9.9% | 1,219,171 | -5.0% | 0.51% | -17.9% |
| Q2 2013 | $88,929,000 | – | 1,283,799 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |